Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Joint Device Feedback Program Between FDA, Private Payors Adds New Participants

Joint Device Feedback Program Between FDA, Private Payors Adds New Participants

Sep 05, 2018
|
staff reporter

NEW YORK (360Dx) – The US Food and Drug Administration today added CareFirst BlueCross BlueShield and United Health Group to its list of private payors participating with the agency to provide presubmission feedback on investigational devices.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  2. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  3. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

  4. BARDA Awards $684K to Luminex for Enhanced COVID-19 Multiplex Antibody Test

  5. FDA Grants Emergency Use Authorization for Jiangsu Well Biotech Coronavirus Antibody Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.